John Frederick Seager

Title: John Frederick Seager: Innovator in Crystalline Complexes

Introduction

John Frederick Seager is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of chemistry, particularly in the development of crystalline complexes. With a total of 4 patents to his name, Seager's work has had a considerable impact on pharmaceutical formulations.

Latest Patents

Among his latest patents, Seager has developed a crystalline complex comprising a compound of formula (I). This complex is characterized by a crystal lattice stabilized by the presence of a guest molecule. The crystalline complex is of space group P222, with unit cell dimensions of about 12.5±1.0 Å, 15±1.0 Å, and 16.2±1.0 Å when determined at either 120K or 150K. Another significant patent involves anti-inflammatory androstane derivative compositions, which also feature a crystalline chemical composition stabilized by a guest molecule. This composition is characterized by a space group P222, with unit cell dimensions of about 7.6±0.6 Å, 12.7±0.7 Å, and 33±3 Å when determined at 120 K.

Career Highlights

Seager has had a distinguished career, working with prominent companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His experience in these organizations has allowed him to refine his expertise in the field of pharmaceutical chemistry.

Collaborations

Throughout his career, Seager has collaborated with notable colleagues, including Keith Biggadike and Steven John Coote. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

John Frederick Seager is a prominent inventor whose work in crystalline complexes has paved the way for advancements in pharmaceutical formulations. His contributions continue to influence the field, showcasing the importance of innovation in science.